TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
A randomized UK trial of 445 older adults with kidney failure and frailty or other health problems found no advantage for either preparing for dialysis or structured conservative kidney management when survival and quality of life were considered together. Only 28% of those assigned to prepare for dialysis started treatment; the findings do not apply to younger, fitter patients or people already receiving dialysis.
A randomized trial led by the University of Bristol found that, for older adults with kidney failure who also have frailty or multiple health conditions, preparing for dialysis did not produce better combined survival and quality-of-life outcomes than preparing for structured care without dialysis. Published in The Lancet, the study challenges treating dialysis as the automatic next step for this group, while leaving treatment choices to patients and their care teams.
The Prepare for Kidney Care trial enrolled 445 people at 31 UK kidney centers, representing about half of the country’s kidney services. Around 75% were aged 80 or older; the remaining participants were 65 to 79 and had additional health problems. Researchers randomly assigned participants to prepare for dialysis or to prepare for responsive management, a form of conservative kidney care that does not include dialysis.
Over an average 4.5 years of follow-up, neither approach was found to be better when length and quality of life were considered together. Among participants assigned to prepare for dialysis, 28% went on to start treatment. The report says people in both groups were more likely to die from other causes than to require dialysis, reflecting the complex health needs of the study population.
The researchers describe conservative kidney management as active treatment without dialysis, rather than the absence of care. Participants could withdraw or change their treatment pathway. The study took nine years to complete, including seven years of recruitment.
A More Individual Approach to Dialysis
The findings give patients, families and clinicians trial evidence for a difficult decision: whether to prepare for dialysis or pursue active kidney care without it when a person is older and living with frailty or other serious health conditions. The result does not establish that the approaches are identical for every patient. It does suggest that dialysis need not be presumed to offer better overall outcomes for this particular group.
That distinction matters because planning for dialysis can shape a person’s care and daily life even when treatment is never started. With only 28% of the dialysis-planning group beginning treatment, the study also underlines the value of discussing likely outcomes and personal priorities early. Researchers and patient advocates say decisions should reflect what matters to each person, including quality of life and comfort, as well as clinical considerations.
The trial may inform discussions about UK kidney services and policy, but it does not itself prescribe a single pathway or show how care should be organized in every setting. The practical implications depend on clinicians having the time and support to explain both options and on patients being able to access the care they choose.
Products Worth Considering
Oral-B iO Series 3 Rechargeable Electric Toothbrush for Adults, Black, 3 Modes, 2 Brush Heads and Travel Case
BowFlex Results Series SelectTech Adjustable Dumbbells (Pair)
Blueair Blue Pure 211i Max Air Purifier for Large Rooms
As an affiliate, we earn on qualifying purchases.
Who the Trial Included
Before this study, the report says, there was limited high-quality evidence directly comparing dialysis planning with conservative kidney management for older people with kidney failure and substantial health needs. The trial was designed to address that gap and to help patients and families make informed choices. Its randomized design compared two care-planning approaches rather than testing dialysis against no treatment.
The results have a specific scope. They concern older adults with kidney failure who were also frail or had multiple health conditions. The report explicitly says they do not apply to people already receiving dialysis or to younger, fitter patients, for whom dialysis and transplantation remain standard care. The findings should not be used to infer that dialysis is unnecessary for those groups.
Participants retained the option to withdraw, and the study allowed them to change their treatment pathway. That flexibility was part of the trial design, which the project lead said was developed to address ethical challenges in comparing care choices.
“The findings will help support more personalized care, patient choice and better-informed decisions.”
— Professor Fliss Murtagh, director of the Wolfson Palliative Care Research Center at the University of Hull
Limits of the Trial Findings
The reported finding is that neither approach performed better when survival and quality of life were considered together. The source does not provide detailed numerical results for each outcome separately, the size of any difference, or subgroup findings that could show whether some participants fared better with one approach. It also does not establish that every person in this age and health group should choose conservative care or dialysis.
The findings cannot be generalized to people already on dialysis or to younger, fitter patients. The report also does not specify how individual clinical factors should determine a particular patient’s choice. Clinicians and patients will need to apply the evidence to personal circumstances, with the study’s population and outcome measures in mind.
Although the trial was intended to inform NHS policy, the source does not announce a policy change, a timetable for implementation, or a plan for expanding services. It remains unclear how consistently both care approaches are available across the UK and what support teams may need to provide informed, patient-led discussions.
Using Results in Kidney Care
The immediate next step is for kidney teams and patients to use the trial as evidence in shared treatment decisions, rather than treating dialysis as an automatic plan for every older adult with frailty and kidney failure. The report says the findings could influence NHS policy, but it does not identify a specific policy decision or implementation date.
Kidney Care UK’s Fiona Loud called for staff to be supported in helping patients make informed choices and for people to receive appropriate care wherever they live. Further policy responses, service planning and research will show how the evidence is incorporated into practice. For individual decisions, the study supports discussion of both options with a qualified kidney-care team; it does not replace personalized clinical advice.
Key Questions
What did the kidney-care trial find?
In this trial of older adults with kidney failure and frailty or other health problems, preparing for dialysis was not better than preparing for structured conservative kidney management when survival and quality of life were considered together.
Does conservative kidney management mean no treatment?
No. The report describes it as active kidney care that does not include dialysis. Participants could change their treatment pathway, including moving on to dialysis if they chose to.
Who took part in the study?
The trial included 445 people at 31 UK kidney centers. About 75% were aged 80 or older; the others were 65 to 79 and had additional health problems.
Does the result apply to all people with kidney failure?
No. The report says the findings do not apply to people already receiving dialysis or to younger, fitter patients, for whom dialysis and transplantation remain standard care.
How many people assigned to prepare for dialysis started it?
Twenty-eight percent of participants assigned to prepare for dialysis went on to start treatment during the study. The report does not give enough detail to interpret that figure as a rate for all older adults with kidney failure.
Source: medicalxpress.com
